Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a compounded combination of four agents commonly used in local and regional anesthesia for surgical, dental, or pain management procedures. Lidocaine and bupivacaine are both amide-type local anesthetics; lidocaine provides rapid onset of anesthesia while bupivacaine offers prolonged duration. Epinephrine (adrenaline) is added as a vasoconstrictor to reduce systemic absorption of the anesthetics, prolong their effect, and decrease bleeding at the injection site. Dexamethasone is a synthetic glucocorticoid corticosteroid included to further prolong analgesia by reducing inflammation and possibly modulating nociceptive pathways. This combination aims to provide fast onset, long-lasting anesthesia/analgesia with reduced postoperative pain and inflammation[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine + bupivacaine + epinephrine + dexamethasone.